Investment capabilities
The Investment division comprises portfolio management, research and dealing functions across Equities, Fixed Income, Multi-asset and Emerging Market Debt, Commodities and Real Estate. We have a broad range of products and solutions that meet investor demand at different phases of the economic and market cycle.
All investment activities are managed with the aim of delivering performance that meets or exceeds client objectives within specific risk parameters. We primarily assess investment performance relative to benchmark and peer group over a market cycle.
Asset Management assets under management
$785.1 billion as at December 31, 2020
Equities includes single country, regional and global funds, small and mid-cap funds, growth, value and quantitative strategies, and defensive strategies to reduce market risk.
INVESTMENT CAPABILITIES
Asia Pacific; Australia; Emerging markets; Europe; Global; Japan; Small and mid-cap; Quantitative equities; UK; US
Equities
US$217.7 billion
Fixed Income employs fundamental and quantitative approaches and is based on research-intensive, globally-integrated credit and macro capabilities.
INVESTMENT CAPABILITIES
Aggregate and multi-strategy; Cash/liquidity; Convertibles; Credit; Emerging market debt relative return; Global; Government; High yield; Insurance-linked securities; Tax-exempt
Fixed Income
US$114.8 billion
Multi-Asset offers a comprehensive range of customized solutions, pooled products and advisory services. We specialize in providing a consultative, solutions-based approach for clients.
INVESTMENT CAPABILITIES
Customised solutions; Liability-driven investments; Multi-asset strategies; Structured investments
Multi-Asset
US$110.7 billion
We manage emerging market debt, commodities and agriculture funds. Our Real Estate business manages a wide range of open and closed-end funds.
INVESTMENT CAPABILITIES
Agriculture; Commodities; Currencies; Direct real estate; Emerging market debt absolute return; Gold and precious metals; Private equity; Real estate securities
Alternatives
US$21.8 billion